These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 34665600)
1. Tetrahedral Framework Nucleic Acids Reverse New-Onset Type 1 Diabetes. Gao S; Zhou M; Li Y; Xiao D; Wang Y; Yao Y; Gao Y; Cai X; Lin Y ACS Appl Mater Interfaces; 2021 Nov; 13(43):50802-50811. PubMed ID: 34665600 [TBL] [Abstract][Full Text] [Related]
2. Tetrahedral Framework Nucleic Acids Reestablish Immune Tolerance and Restore Saliva Secretion in a Sjögren's Syndrome Mouse Model. Gao S; Wang Y; Li Y; Xiao D; Lin Y; Chen Y; Cai X ACS Appl Mater Interfaces; 2021 Sep; 13(36):42543-42553. PubMed ID: 34477358 [TBL] [Abstract][Full Text] [Related]
3. Tetrahedral Framework Nucleic Acids Induce Immune Tolerance and Prevent the Onset of Type 1 Diabetes. Gao S; Li Y; Xiao D; Zhou M; Cai X; Lin Y Nano Lett; 2021 May; 21(10):4437-4446. PubMed ID: 33955221 [TBL] [Abstract][Full Text] [Related]
4. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice. Xia CQ; Peng R; Qiu Y; Annamalai M; Gordon D; Clare-Salzler MJ Diabetes; 2007 Aug; 56(8):2116-23. PubMed ID: 17496235 [TBL] [Abstract][Full Text] [Related]
5. Butyrate induced Tregs are capable of migration from the GALT to the pancreas to restore immunological tolerance during type-1 diabetes. Jacob N; Jaiswal S; Maheshwari D; Nallabelli N; Khatri N; Bhatia A; Bal A; Malik V; Verma S; Kumar R; Sachdeva N Sci Rep; 2020 Nov; 10(1):19120. PubMed ID: 33154424 [TBL] [Abstract][Full Text] [Related]
6. IL-2 immunotherapy reveals potential for innate beta cell regeneration in the non-obese diabetic mouse model of autoimmune diabetes. Diaz-de-Durana Y; Lau J; Knee D; Filippi C; Londei M; McNamara P; Nasoff M; DiDonato M; Glynne R; Herman AE PLoS One; 2013; 8(10):e78483. PubMed ID: 24205242 [TBL] [Abstract][Full Text] [Related]
7. Engineered PD-L1-Expressing Platelets Reverse New-Onset Type 1 Diabetes. Zhang X; Kang Y; Wang J; Yan J; Chen Q; Cheng H; Huang P; Gu Z Adv Mater; 2020 Jul; 32(26):e1907692. PubMed ID: 32449212 [TBL] [Abstract][Full Text] [Related]
8. Myeloid-derived suppressor cells prevent type 1 diabetes in murine models. Yin B; Ma G; Yen CY; Zhou Z; Wang GX; Divino CM; Casares S; Chen SH; Yang WC; Pan PY J Immunol; 2010 Nov; 185(10):5828-34. PubMed ID: 20956337 [TBL] [Abstract][Full Text] [Related]
9. Reversal of New Onset Type 1 Diabetes by Oral Mbongue JC; Rawson J; Garcia PA; Gonzalez N; Cobb J; Kandeel F; Ferreri K; Husseiny MI Front Immunol; 2019; 10():320. PubMed ID: 30863412 [TBL] [Abstract][Full Text] [Related]
10. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice. Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946 [TBL] [Abstract][Full Text] [Related]
12. Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-beta? Song L; Wang J; Wang R; Yu M; Sun Y; Han G; Li Y; Qian J; Scott DW; Kang Y; Soukhareva N; Shen B Gene Ther; 2004 Oct; 11(20):1487-96. PubMed ID: 15343360 [TBL] [Abstract][Full Text] [Related]
13. The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes. Pearson JA; Wong FS; Wen L J Autoimmun; 2016 Jan; 66():76-88. PubMed ID: 26403950 [TBL] [Abstract][Full Text] [Related]
14. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy. Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973 [TBL] [Abstract][Full Text] [Related]
15. Apoptotic non-beta cells suppress beta cell antigen-reactive T cells and induce beta cell antigen-specific regulatory T cells. Xia CQ; Qiu Y; Peng R; Lo-Dauer J; Clare-Salzler MJ Ann N Y Acad Sci; 2008 Dec; 1150():167-70. PubMed ID: 19120288 [TBL] [Abstract][Full Text] [Related]
16. CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells. Mukherjee R; Chaturvedi P; Qin HY; Singh B J Autoimmun; 2003 Nov; 21(3):221-37. PubMed ID: 14599847 [TBL] [Abstract][Full Text] [Related]
17. Early-life fingolimod treatment improves intestinal homeostasis and pancreatic immune tolerance in non-obese diabetic mice. Jia LL; Zhang M; Liu H; Sun J; Pan LL Acta Pharmacol Sin; 2021 Oct; 42(10):1620-1629. PubMed ID: 33473182 [TBL] [Abstract][Full Text] [Related]
18. Curative and beta cell regenerative effects of alpha1-antitrypsin treatment in autoimmune diabetic NOD mice. Koulmanda M; Bhasin M; Hoffman L; Fan Z; Qipo A; Shi H; Bonner-Weir S; Putheti P; Degauque N; Libermann TA; Auchincloss H; Flier JS; Strom TB Proc Natl Acad Sci U S A; 2008 Oct; 105(42):16242-7. PubMed ID: 18852471 [TBL] [Abstract][Full Text] [Related]
19. Insulin B chain 9-23 gene transfer to hepatocytes protects from type 1 diabetes by inducing Ag-specific FoxP3+ Tregs. Akbarpour M; Goudy KS; Cantore A; Russo F; Sanvito F; Naldini L; Annoni A; Roncarolo MG Sci Transl Med; 2015 May; 7(289):289ra81. PubMed ID: 26019217 [TBL] [Abstract][Full Text] [Related]